SCHEMBL13061402

SCHEMBL13061402

CCCCOc1c(OC)ccc2c(=O)n(C)ccc12

nearest known ligand 0.59

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 8/20 0.59
MTNR1A P48039 1/20 0.59
MTNR1B P49286 1/20 0.59
LMNA P02545 3/20 0.40
POLB P06746 2/20 0.40
TP53 P04637 2/20 0.40
MAPT P10636 2/20 0.40
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
GRM2 Q14416 1/20 0.39
CYP2C9 P11712 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13007331 0.80 MTNR1A (0.58) CNR2MTNR1AMTNR1BLMNAPOLB
SCHEMBL13007327 0.79 MTNR1A (0.77) CNR2MTNR1AMTNR1BTP53MAPT
SCHEMBL13007345 0.77 MTNR1B (0.81) CNR2MTNR1AMTNR1BLMNAPOLB
SCHEMBL4415634 0.77 CNR2 (0.81) CNR2MTNR1AMTNR1BALDH1A1KDM4E
SCHEMBL4415364 0.76 CNR2 (0.83) CNR2MTNR1AMTNR1BGRM2
SCHEMBL13007340 0.75 MTNR1A (0.68) CNR2MTNR1AMTNR1BGRM2
SCHEMBL4407773 0.75 CNR2 (0.81) CNR2MTNR1AMTNR1BGRM2
SCHEMBL4411477 0.75 CNR2 (1.00) CNR2MTNR1AMTNR1BLMNAPOLB
SCHEMBL4408457 0.75 CNR2 (1.00) CNR2MTNR1AMTNR1BLMNAGRM2
Hydrochloric Acid SCHEMBL4408555 0.74 CNR2 (0.80) CNR2MTNR1AMTNR1BGRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8389544-B2 Isoquinolone compounds as subtype-selective agonists for melatonin receptors MT1 and MT2 THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2013-03-05 US disclosed
US-20100317691-A1 ISOQUINOLONE COMPOUNDS AS SUBTYPE-SELECTIVE AGONISTS FOR MELATONIN RECEPTORS MT1 AND MT2 THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2010-12-16 US disclosed
WO-2008092292-A1 ISOQUINOLONE COMPOUNDS AS SUBTYPE-SELECTIVE AGONISTS FOR MELATONIN RECEPTORS MT1 AND MT2 THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2008-08-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317691-A1 ISOQUINOLONE COMPOUNDS AS SUBTYPE-SELECTIVE AGONISTS FOR MELATONIN RECEPTORS MT1 AND MT2 MTNR1A, MTNR1B, MC2R CNR2 37/4885MTNR1A 1/4885MTNR1B 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.